HP9-23568-69663
4 vaccinations
5 coded responses
33 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 146 / NY
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
-
2021-04-15
Survey response — day 14, dose 1MedDRA: Headache, New daily persistent headache — Feeling: FairFree text: Headaches daily for the past 4 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-24
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congestion and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-07-22
- 2021-10-21
-
2021-12-13
Dose 3 — Moderna
- 2022-04-22
-
2022-12-05
Dose 4 — Pfizer-BioNTech
- 2022-12-10
- 2022-12-11
- 2022-12-12
- 2022-12-19
- 2022-12-26
- 2023-01-02
- 2023-01-09
- 2023-01-16
-
2023-03-06
Survey response — 3 months, dose 4MedDRA: Anosmia, COVID-19, Cough, Headache, Oropharyngeal pain, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-06-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Moderna | No |
| 4 | 2022-12-05 | Pfizer-BioNTech | No |
Free text
Release 7 — day 14, dose 1
Symptoms: Headaches daily for the past 4 days
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Systemic reaction (other): Congestion and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | New daily persistent headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release